Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2144PDF: 1552HTML: 513 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1422PDF: 829HTML: 3124 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3383PDF: 1492HTML: 4016 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1353PDF: 1241HTML: 462 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1317PDF: 608HTML: 3104 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2202PDF: 1616HTML: 314 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1702PDF: 819HTML: 938cover letter: 274 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
1989PDF: 76HTML: 21 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1986PDF: 827HTML: 2206Table 1: 184Table 2: 204Table 3: 198Table 4: 203Table 5: 198Tble 6: 191Cover Letter: 211Greene Tab.7: 201 -
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2309PDF: 1170HTML: 652 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4823PDF: 2871HTML: 2311 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4148PDF: 1955HTML: 5330Table 1: 201 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1657PDF: 1105HTML: 127 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1670PDF: 1250HTML: 266 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3666PDF: 904HTML: 6722 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1404HTML: 475PDF: 836 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2404PDF: 1009HTML: 1654Fig 1: 190Tab I: 219Cover Letter: 211 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1217PDF: 929HTML: 291







